Colorectal cancer immunotherapy-Recent progress and future directions
W Zhao, L Jin, P Chen, D Li, W Gao, G Dong - Cancer letters, 2022 - Elsevier
Compared with conventional chemotherapy and targeted therapy, immunotherapy has
changed the treatment prospects of various solid tumors and has recently become the main …
changed the treatment prospects of various solid tumors and has recently become the main …
[HTML][HTML] Colorectal cancer vaccines: The current scenario and future prospects
W Jia, T Zhang, H Huang, H Feng, S Wang… - Frontiers in …, 2022 - frontiersin.org
Colorectal cancer (CRC) is one of the most common cancers worldwide. Current therapies
such as surgery, chemotherapy, and radiotherapy encounter obstacles in preventing …
such as surgery, chemotherapy, and radiotherapy encounter obstacles in preventing …
Trial watch: Dendritic cell-based interventions for cancer therapy
Dendritic cells (DCs) occupy a central position in the immune system, orchestrating a wide
repertoire of responses that span from the development of self-tolerance to the elicitation of …
repertoire of responses that span from the development of self-tolerance to the elicitation of …
Tuning Bacterial Morphology to Enhance Anticancer Vaccination
CX Li, Y Qi, Y Chen, Y Zhang, B Li, J Feng, XZ Zhang - ACS nano, 2023 - ACS Publications
Morphology tuning is a potent strategy to modulate physiological effects of synthetic
biomaterials, but it is rarely explored in microbe-based biochemicals due to the lack of …
biomaterials, but it is rarely explored in microbe-based biochemicals due to the lack of …
Cellular vaccine approaches
Therapeutic cancer vaccines aim to generate immunologic targeting of cancer cells through
the induction of effective cellular and antibody-mediated responses specific for antigens …
the induction of effective cellular and antibody-mediated responses specific for antigens …
Autologous dendritic cells pulsed with allogeneic tumor cell lysate in mesothelioma: from mouse to human
JGJV Aerts, PL de Goeje, R Cornelissen… - Clinical Cancer …, 2018 - AACR
Purpose: Mesothelioma has been regarded as a nonimmunogenic tumor, which is also
shown by the low response rates to treatments targeting the PD-1/PD-L1 axis. Previously …
shown by the low response rates to treatments targeting the PD-1/PD-L1 axis. Previously …
Immunotherapy for medulloblastoma: current perspectives
TF Kabir, CA Kunos, JL Villano… - ImmunoTargets and …, 2020 - Taylor & Francis
Background Immune-mediated therapies have transformed the treatment of metastatic
melanoma and renal, bladder, and both small and non-small cell lung carcinomas …
melanoma and renal, bladder, and both small and non-small cell lung carcinomas …
Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
There are increasing incidences and mortality rates for colorectal cancer in the world. It is
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
common for chemotherapy and radiation given to patients with colorectal cancer to cause …
Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells
R Aguilera, C Saffie, A Tittarelli, FE González… - Clinical Cancer …, 2011 - AACR
Purpose: This study characterizes, biologically and clinically, a novel type of dendritic cells
(DC) produced in the short term and called tumor antigen–presenting cells (TAPCells). In …
(DC) produced in the short term and called tumor antigen–presenting cells (TAPCells). In …
[HTML][HTML] Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced …
M Caballero-Baños, D Benitez-Ribas, J Tabera… - European Journal of …, 2016 - Elsevier
Background Autologous tumour lysate dendritic cell vaccine (ADC) has T-cell stimulatory
capacity and, therefore, potential antitumour activity. We designed a phase II randomised …
capacity and, therefore, potential antitumour activity. We designed a phase II randomised …